Search details
1.
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
N Engl J Med
; 384(18): 1705-1718, 2021 05 06.
Article
in English
| MEDLINE | ID: mdl-33951360
2.
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
Am J Respir Crit Care Med
; 207(10): 1376-1382, 2023 05 15.
Article
in English
| MEDLINE | ID: mdl-36790881
3.
Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen.
Clin Trials
; 17(1): 39-51, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31690107
4.
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection.
MMWR Morb Mortal Wkly Rep
; 67(25): 723-726, 2018 Jun 29.
Article
in English
| MEDLINE | ID: mdl-29953429
5.
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada.
Clin Infect Dis
; 62(11): 1390-1400, 2016 06 01.
Article
in English
| MEDLINE | ID: mdl-26951571
6.
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
Am J Respir Crit Care Med
; 191(3): 333-43, 2015 Feb 01.
Article
in English
| MEDLINE | ID: mdl-25489785
7.
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
J Infect Dis
; 206(7): 1030-40, 2012 Oct 01.
Article
in English
| MEDLINE | ID: mdl-22850121
8.
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
MMWR Recomm Rep
; 59(RR-5): 1-25, 2010 Jun 25.
Article
in English
| MEDLINE | ID: mdl-20577159
9.
Optimizing drug inventory management with a web-based information system: The TBTC Study 31/ACTG A5349 experience.
Contemp Clin Trials
; 105: 106377, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33794353
10.
Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.
J Clin Microbiol
; 48(12): 4370-6, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-20926712
11.
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
Am J Respir Crit Care Med
; 180(3): 273-80, 2009 Aug 01.
Article
in English
| MEDLINE | ID: mdl-19406981
12.
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.
Contemp Clin Trials
; 90: 105938, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31981713
13.
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.
Ann Am Thorac Soc
; 15(5): 570-580, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29393655
14.
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.
Lancet Respir Med
; 6(4): 265-275, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29595509
15.
Evaluation of the Informed Consent Process of a Multicenter Tuberculosis Treatment Trial.
AJOB Empir Bioeth
; 6(4): 31-43, 2015.
Article
in English
| MEDLINE | ID: mdl-28317002
16.
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
JAMA Pediatr
; 169(3): 247-55, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25580725
17.
How we determined the most reliable solid medium for studying treatment of tuberculosis.
Tuberculosis (Edinb)
; 94(3): 317-22, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24661816
18.
What is the most reliable solid culture medium for tuberculosis treatment trials?
Tuberculosis (Edinb)
; 94(3): 311-6, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24698569
19.
The association between symptoms and microbiologically defined response to tuberculosis treatment.
Ann Am Thorac Soc
; 10(1): 18-25, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23509328
20.
Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment.
PLoS One
; 8(12): e81564, 2013.
Article
in English
| MEDLINE | ID: mdl-24324704